164 related articles for article (PubMed ID: 36826995)
41. Inducible T-cell co-stimulator: Signaling mechanisms in T follicular helper cells and beyond.
Panneton V; Chang J; Witalis M; Li J; Suh WK
Immunol Rev; 2019 Sep; 291(1):91-103. PubMed ID: 31402504
[TBL] [Abstract][Full Text] [Related]
42. Abnormalities of follicular helper T-cell number and function in Wiskott-Aldrich syndrome.
Zhang X; Dai R; Li W; Zhao H; Zhang Y; Zhou L; Du H; Luo G; Wu J; Niu L; An Y; Zhang Z; Ding Y; Song W; Liu C; Zhao X
Blood; 2016 Jun; 127(25):3180-91. PubMed ID: 27170596
[TBL] [Abstract][Full Text] [Related]
43. [Peripheral T-cell lymphoma with follicular helper of T cell phenotype of Waldeyer's ring: a clinicopathological and genetic study of eight cases].
Zhang DD; Li P; Hu PZ; Wang GN; Zhao WG; Zhang YP; Li WC
Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):686-692. PubMed ID: 32610379
[No Abstract] [Full Text] [Related]
44. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
45. High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis.
Wang J; Shan Y; Jiang Z; Feng J; Li C; Ma L; Jiang Y
Clin Exp Immunol; 2013 Nov; 174(2):212-20. PubMed ID: 23786438
[TBL] [Abstract][Full Text] [Related]
46. Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
Ma H; O'Connor OA; Marchi E
Semin Hematol; 2021 Apr; 58(2):95-102. PubMed ID: 33906727
[TBL] [Abstract][Full Text] [Related]
47. miR-192 suppresses T follicular helper cell differentiation by targeting CXCR5 in childhood asthma.
Zhang D; Wu Y; Sun G
Scand J Clin Lab Invest; 2018 May; 78(3):236-242. PubMed ID: 29490514
[TBL] [Abstract][Full Text] [Related]
48. Expression of Master Regulators of T-cell, Helper T-cell and Follicular Helper T-cell Differentiation in Angioimmunoblastic T-cell Lymphoma.
Matsumoto Y; Nagoshi H; Yoshida M; Kato S; Kuroda J; Shimura K; Kaneko H; Horiike S; Nakamura S; Taniwaki M
Intern Med; 2017 Nov; 56(21):2851-2856. PubMed ID: 28943543
[TBL] [Abstract][Full Text] [Related]
49. Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases.
Battistella M; Beylot-Barry M; Bachelez H; Rivet J; Vergier B; Bagot M
Arch Dermatol; 2012 Jul; 148(7):832-9. PubMed ID: 22508770
[TBL] [Abstract][Full Text] [Related]
50. Circulating follicular helper T cells exhibit reduced ICOS expression and impaired function in narcolepsy type 1 patients.
Nguyen XH; Dauvilliers Y; Quériault C; Perals C; Romieu-Mourez R; Paulet PE; Bernard-Valnet R; Fazilleau N; Liblau R
J Autoimmun; 2018 Nov; 94():134-142. PubMed ID: 30104107
[TBL] [Abstract][Full Text] [Related]
51. Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
Mihashi Y; Kimura S; Iwasaki H; Oshiro Y; Takamatsu Y; Kawauchi S; Shimajiri S; Ishizuka K; Takeshita M
Diagn Pathol; 2021 Nov; 16(1):101. PubMed ID: 34742294
[TBL] [Abstract][Full Text] [Related]
52. Identification of CD4
Hoog A; Villanueva-Hernández S; Razavi MA; van Dongen K; Eder T; Piney L; Chapat L; de Luca K; Grebien F; Mair KH; Gerner W
Dev Comp Immunol; 2022 Sep; 134():104462. PubMed ID: 35667468
[TBL] [Abstract][Full Text] [Related]
53. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers.
Rodriguez-Justo M; Attygalle AD; Munson P; Roncador G; Marafioti T; Piris MA
Mod Pathol; 2009 Jun; 22(6):753-61. PubMed ID: 19329936
[TBL] [Abstract][Full Text] [Related]
54. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
[TBL] [Abstract][Full Text] [Related]
55. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
56. Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's Syndrome.
Verstappen GM; Meiners PM; Corneth OBJ; Visser A; Arends S; Abdulahad WH; Hendriks RW; Vissink A; Kroese FGM; Bootsma H
Arthritis Rheumatol; 2017 Sep; 69(9):1850-1861. PubMed ID: 28564491
[TBL] [Abstract][Full Text] [Related]
57. Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study.
Michot JM; Bouabdallah R; Vitolo U; Doorduijn JK; Salles G; Chiappella A; Zinzani PL; Bijou F; Kersten MJ; Sarmiento R; Mosulen S; Mendez C; Uttamsingh S; Pourdehnad M; Hege K; Chen T; Klein C; Hagner PR; Nikolova Z; Ribrag V
Lancet Haematol; 2020 Sep; 7(9):e649-e659. PubMed ID: 32758434
[TBL] [Abstract][Full Text] [Related]
58. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
59. ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2.
Weber JP; Fuhrmann F; Feist RK; Lahmann A; Al Baz MS; Gentz LJ; Vu Van D; Mages HW; Haftmann C; Riedel R; Grün JR; Schuh W; Kroczek RA; Radbruch A; Mashreghi MF; Hutloff A
J Exp Med; 2015 Feb; 212(2):217-33. PubMed ID: 25646266
[TBL] [Abstract][Full Text] [Related]
60. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
